Search - tctmd.com

Displaying 481 - 500 of 603

Sort: Relevancy | Date

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

News Daily News

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

February 25, 2013

News Daily News

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

February 25, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

Yael L. Maxwell

January 13, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

January 07, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

Presentation

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Presenter: J. Yu

December 17, 2012

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Caitlin E. Cox

December 16, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Daily News

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

L.A. McKeown

November 28, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Conference News AHA 2012

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

November 05, 2012

Advertisement

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content